Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...

Radiography and computed tomography (CT) of the chest reportedly showed ... smoking-related lung cancer in his maternal grandmother; and pancreatic cancer in his maternal grandfather.

Our photon-counting CT is changing clinical practice across disciplines. It revolutionizes the clinical relevance of CT. Here are three examples ... Example two, pancreatic cancer is one of ...

Cedars-Sinai investigators are developing a tool using artificial intelligence to help predict pancreatic cancer in Black ...

Oncosil is making a Big Push into Europe with the device, which delivers targeted radiation directly to inoperable pancreatic tumours ... is to develop a full-body portable computed tomography (CT) ...

The liver produces CRP, an acute-phase protein, in response to the pro ... such as measuring pancreatic attenuation through non-enhanced CT images with three regions of interest (ROIs) on the head, ...

RESULTS The three groups were well matched with respect ... Contrast enhanced computed tomography (CT) was performed within 96 hours in 264 (87%) of the 302 patients; pancreatic oedema with exudate, ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and possible regeneration. Laura is an assistant editor for The Scientist. She ...

Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic ... back at a three-year follow-up compared with patients whose immune systems did not ...

Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial succeeds. But the broker said that with a successful Phase III trial, that ...